Aurobindo Pharma Falls After U.S. FDA Classifies Three Plants For Official Action
A man rides past an Aurobindo Pharma Ltd. production facility in Jadcherla in Telangana. (Photographer: Prashanth Vishwanathan/Bloomberg)

Aurobindo Pharma Falls After U.S. FDA Classifies Three Plants For Official Action

Shares of Aurobindo Pharma Ltd. slumped in early trade today after it informed the exchanges that the American drug regulator has classified three of its plants that export to the U.S. as “official...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.